Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.9K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.1K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

5.6K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.6K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.7K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

10.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective Inhibition of KRASG13C Reveals an Increased Dependence on Wild-Type RAS Isoforms in Codon 13 RAS-Mutant Cancers.

Cancer discovery·2026
Same author

Targeting KRAS codon 13 mutations using direct combination approaches in non-small cell lung cancer.

Cancer discovery·2026
Same author

Distinct ERK and PI3K dependencies mediate a heterogeneous response to RAS(ON) inhibition in KRAS-mutant colorectal cancer.

Cell reports·2026
Same author

The Effect of Age, Sex, and Body Mass Index on Spinopelvic Balance Throughout Childhood and Adolescence: An Automated 3D-Computed Tomography Study of 9,721 Pediatric Patients.

Journal of the Pediatric Orthopaedic Society of North America·2026
Same author

Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multi-Selective Inhibitors in NRAS-Mutated Melanoma.

Cancer research·2026
Same author

Disrupted molecular glue complex drives RAS inhibitor resistance.

Cell·2026

Related Experiment Video

Updated: Dec 2, 2025

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

7.9K

Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity.

Darienne R Myers1, Clare L Abram2, David Wildes1

  • 1Revolution Medicines, Inc., Redwood City, CA, United States.

Frontiers in Immunology
|November 2, 2020
PubMed
Summary

Inhibiting Shp1 (a protein tyrosine phosphatase) enhances anti-tumor immunity by boosting innate and adaptive immune cells. This approach shows promise for cancer immunotherapy, though potential toxicity requires consideration.

Keywords:
PTPN6SIRPαimmuno-oncologyinflammationphagocytosistyrosine phosphatase

More Related Videos

Preparation of Myeloid Derived Suppressor Cells MDSC from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting AutoMACS
14:15

Preparation of Myeloid Derived Suppressor Cells MDSC from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting AutoMACS

Published on: June 18, 2012

26.6K
Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
09:23

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

Published on: October 20, 2016

14.6K

Related Experiment Videos

Last Updated: Dec 2, 2025

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

7.9K
Preparation of Myeloid Derived Suppressor Cells MDSC from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting AutoMACS
14:15

Preparation of Myeloid Derived Suppressor Cells MDSC from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting AutoMACS

Published on: June 18, 2012

26.6K
Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
09:23

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

Published on: October 20, 2016

14.6K

Area of Science:

  • Immunology
  • Cancer Biology
  • Biochemistry

Background:

  • Shp1 (protein tyrosine phosphatase) regulates immune cell signaling.
  • Shp1 inhibition is a potential cancer immunotherapy strategy.
  • Antibodies targeting CD47-SIRPα enhance phagocytosis and anti-tumor activity.

Purpose of the Study:

  • To investigate Shp1's role in anti-tumor immunity.
  • To evaluate the therapeutic potential of Shp1 inhibition in preclinical cancer models.

Main Methods:

  • Assessed Shp1 binding to SIRPα peptides.
  • Utilized a novel inducible mouse model for Ptpn6 deletion.
  • Evaluated anti-tumor immunity in MC38, E0771, and B16F10 syngeneic tumor models.

Main Results:

  • Shp1 loss in macrophages increased tumor cell phagocytosis in vitro.
  • Inducible Shp1 deletion caused inflammatory disease in mice.
  • Shp1 loss promoted anti-tumor immunity in MC38 and E0771 models, increasing myeloid cells and effector T cells (E0771) or IFNγ (MC38).
  • No anti-tumor activity was observed in the non-inflamed B16F10 model.

Conclusions:

  • Shp1 inhibition enhances innate and adaptive anti-tumor immune responses.
  • Targeting Shp1 is a promising strategy for cancer immunotherapy.
  • Acute Shp1 perturbation may drive beneficial immune hyperactivation, but carries risks of toxicity.